{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:24:38Z","timestamp":1787397878155,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Youth Teacher Research Capacity Improvement Plan Project of the Higher Education Institutions Directly Affiliated to the Inner Mongolia Autonomous Region","award":["NGJGH2022269"],"award-info":[{"award-number":["NGJGH2022269"]}]},{"name":"Joint Fund Project of the Natural Science Foundation of Inner Mongolia Autonomous Region","award":["2021LHMS08032"],"award-info":[{"award-number":["2021LHMS08032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04288-7","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:29:48Z","timestamp":1772897388000},"page":"3941-3958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative metabolomics and network pharmacology reveal the antifibrotic mechanisms of Gurigumu-13 in a rat model of hepatic fibrosis"],"prefix":"10.1007","volume":"28","author":[{"given":"Shuping","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Anni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sudulugeqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3894-0342","authenticated-orcid":false,"given":"Wenbo","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"7","key":"4288_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.cgh.2024.08.020","volume":"23","author":"M Zamani","year":"2024","unstructured":"Zamani M, et al. Global prevalence of advanced liver fibrosis and cirrhosis in the general population: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2024;23(7):1123\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"4288_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.aohep.2020.01.003","volume":"19","author":"D Garc\u00eda-Compe\u00e1n","year":"2020","unstructured":"Garc\u00eda-Compe\u00e1n D, et al. Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. time for screening? Ann Hepatol. 2020;19(3):258\u201364.","journal-title":"Ann Hepatol"},{"key":"4288_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2025.2454247","author":"K Saarinen","year":"2025","unstructured":"Saarinen K, et al. The use of ELF in predicting liver fibrosis prevalence and fibrosis progression in the general population. Scand J Gastroenterol. 2025. https:\/\/doi.org\/10.1080\/00365521.2025.2454247.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"4288_CR4","first-page":"504","volume":"32","author":"AC Adejumo","year":"2019","unstructured":"Adejumo AC, et al. Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States. Ann Gastroenterol. 2019;32(5):504\u201313.","journal-title":"Ann Gastroenterol"},{"issue":"37","key":"4288_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039725","volume":"103","author":"J Zhao","year":"2024","unstructured":"Zhao J, et al. Exploring the mechanism of action of Bidens pilosa L. in combating hepatic fibrosis through network pharmacology and molecular docking: an observational study. Med (Baltimore). 2024;103(37):e39725.","journal-title":"Med (Baltimore)"},{"key":"4288_CR6","doi-asserted-by":"publisher","first-page":"930785","DOI":"10.3389\/fphar.2022.930785","volume":"13","author":"K Chang","year":"2022","unstructured":"Chang K, et al. Ganfule capsule alleviates bile duct ligation-induced liver fibrosis in mice by inhibiting glutamine metabolism. Front Pharmacol. 2022;13:930785.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4288_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","volume":"68","author":"D Schuppan","year":"2018","unstructured":"Schuppan D, Surabattula R, Wang XY. Determinants of fibrosis progression and regression in NASH. J Hepatol. 2018;68(2):238\u201350.","journal-title":"J Hepatol"},{"issue":"1","key":"4288_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12909-019-1856-8","volume":"19","author":"YC Chiu","year":"2019","unstructured":"Chiu YC, et al. To examine the associations between medical students\u2019 conceptions of learning, strategies to learning, and learning outcome in a medical humanities course. BMC Med Educ. 2019;19(1):410.","journal-title":"BMC Med Educ"},{"issue":"9","key":"4288_CR9","first-page":"3","volume":"14","author":"Q Cao","year":"2008","unstructured":"Cao Q. Gurigumu-13 (a 13-herb Mongolian formula) for the treatment of drug-induced liver injury. J Med Pharm Chin Minorityies (in Chinese). 2008;14(9):3\u20133.","journal-title":"J Med Pharm Chin Minorityies (in Chinese)"},{"issue":"11","key":"4288_CR10","first-page":"19","volume":"18","author":"DW Dao Ligema","year":"2022","unstructured":"Dao Ligema DW, Chula S, Richu S, Yuanyuan C, Geer BT, Taogeshen B. Study on the ameliorative effect of mongolian medicine Gurigumu-13 on CCl4 induced liver fibrosis in rats and its mechanism (in Chinese). Tradit Med Asia Pac. 2022;18(11):19\u201323.","journal-title":"Tradit Med Asia Pac"},{"issue":"2","key":"4288_CR11","first-page":"4","volume":"26","author":"G Yuedong","year":"2020","unstructured":"Yuedong G, et al. Study on the protective effects of Gurigumu and Gurigumu-13 on rats with chronic alcoholic liver fibrosis (in Chinese). Chin J Ethn Med Pharm. 2020;26(2):4.","journal-title":"Chin J Ethn Med Pharm"},{"key":"4288_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI179710","author":"S Marcella","year":"2024","unstructured":"Marcella S, et al. Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction-associated steatohepatitis. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI179710.","journal-title":"J Clin Invest"},{"key":"4288_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/20420188241242937","author":"A Waleed","year":"2024","unstructured":"Waleed A, Mahmoud M, Saleh A A. Gut microbiota in MAFLD: therapeutic and diagnostic implications. Ther Adv Endocrinol Metab. 2024. https:\/\/doi.org\/10.1177\/20420188241242937.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"4288_CR14","doi-asserted-by":"publisher","DOI":"10.26502\/acbr.50170125","author":"J Chunyan","year":"2020","unstructured":"Chunyan J, et al. Traditional Chinese medicine Fuzheng Huayu prevents development of liver fibrosis in mice. Arch Clin Biomed Res. 2020. https:\/\/doi.org\/10.26502\/acbr.50170125.","journal-title":"Arch Clin Biomed Res"},{"issue":"4","key":"4288_CR15","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/HEP.0000000000001018","volume":"81","author":"U Ojha","year":"2025","unstructured":"Ojha U, et al. Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis. Hepatology. 2025;81(4):1228\u201343.","journal-title":"Hepatology"},{"key":"4288_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-1-0716-1382-5_23","volume":"2299","author":"A Ravichandra","year":"2021","unstructured":"Ravichandra A, Schwabe RF. Mouse models of liver fibrosis. Methods Mol Biol. 2021;2299:339\u201356.","journal-title":"Methods Mol Biol"},{"key":"4288_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107664","volume":"214","author":"J Zhang","year":"2025","unstructured":"Zhang J, et al. Liver-specific inactivation of Cideb improves metabolic profiles and ameliorates steatohepatitis and fibrosis in animal models for MASH. Pharmacol Res. 2025;214:107664.","journal-title":"Pharmacol Res"},{"issue":"8","key":"4288_CR18","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3390\/antiox12081588","volume":"12","author":"K Jihyun","year":"2023","unstructured":"Jihyun K, et al. Integrative transcriptomic analysis reveals upregulated apoptotic signaling in wound-healing pathway in rat liver fibrosis models. Antioxid (Basel). 2023;12(8):1588.","journal-title":"Antioxid (Basel)"},{"key":"4288_CR19","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.012062","author":"G Matthew","year":"2014","unstructured":"Matthew G, William C P. Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech. 2014. https:\/\/doi.org\/10.1242\/dmm.012062.","journal-title":"Dis Model Mech"},{"key":"4288_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274126","author":"K Mrigendra Bir","year":"2022","unstructured":"Mrigendra Bir K, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) shows therapeutic effect on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. PLoS ONE. 2022. https:\/\/doi.org\/10.1371\/journal.pone.0274126.","journal-title":"PLoS ONE"},{"key":"4288_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2025.116668","volume":"257","author":"Z Hu","year":"2025","unstructured":"Hu Z, et al. Enhanced bile acid detection and analysis in liver fibrosis with pseudo-targeted metabolomics. J Pharm Biomed Anal. 2025;257:116668.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"4288_CR22","doi-asserted-by":"publisher","first-page":"20035","DOI":"10.1038\/s41598-024-70281-1","volume":"14","author":"G Ji","year":"2024","unstructured":"Ji G, et al. Comprehensive evaluation of the mechanism of human adipose mesenchymal stem cells ameliorating liver fibrosis by transcriptomics and metabolomics analysis. Sci Rep. 2024;14(1):20035.","journal-title":"Sci Rep"},{"key":"4288_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117516","volume":"321","author":"T Lan","year":"2024","unstructured":"Lan T, et al. Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK\/NF-\u03baB signaling pathway. J Ethnopharmacol. 2024;321:117516.","journal-title":"J Ethnopharmacol"},{"key":"4288_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103029","volume":"69","author":"Y Fu","year":"2024","unstructured":"Fu Y, et al. Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis. Redox Biol. 2024;69:103029.","journal-title":"Redox Biol"},{"key":"4288_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00582","author":"H Wei","year":"2019","unstructured":"Wei H, et al. Prediction of VEGF-C as a key target of pure total flavonoids from Citrus against NAFLD in mice via network pharmacology. Front Pharmacol. 2019. https:\/\/doi.org\/10.3389\/fphar.2019.00582.","journal-title":"Front Pharmacol"},{"key":"4288_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-024-04740-6","author":"L Yue","year":"2024","unstructured":"Yue L, et al. Investigation of the mechanism of baicalein in the treatment of periodontitis based on network pharmacology, molecular docking and experimental validation. BMC Oral Health. 2024. https:\/\/doi.org\/10.1186\/s12903-024-04740-6.","journal-title":"BMC Oral Health"},{"key":"4288_CR27","first-page":"61","volume":"17","author":"Q Li","year":"2025","unstructured":"Li Q, et al. Network pharmacology and experimental validation of the therapeutic effect of Baji Capsule on LPS-induced osteoporosis. Orthop Res Rev. 2025;17:61\u201381.","journal-title":"Orthop Res Rev"},{"issue":"1","key":"4288_CR28","doi-asserted-by":"publisher","first-page":"28943","DOI":"10.1038\/s41598-024-80616-7","volume":"14","author":"X Chen","year":"2024","unstructured":"Chen X, et al. Integrative metabolomics and proteomics reveal the effect and mechanism of Zi Qi decoction on alleviating liver fibrosis. Sci Rep. 2024;14(1):28943.","journal-title":"Sci Rep"},{"issue":"51","key":"4288_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000041028","volume":"103","author":"Y Wu","year":"2024","unstructured":"Wu Y, Yue S. Network pharmacology unveils the active components and potential mechanism of traditional efficacy of Mugua. Med (Baltimore). 2024;103(51):e41028.","journal-title":"Med (Baltimore)"},{"issue":"21","key":"4288_CR30","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/bioinformatics\/btn323","volume":"24","author":"D Kessner","year":"2008","unstructured":"Kessner D, et al. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics. 2008;24(21):2534\u20136.","journal-title":"Bioinformatics"},{"issue":"D1","key":"4288_CR31","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart DS, et al. HMDB 5.0: the Human Metabolome Database for 2022. Nucleic Acids Res. 2022;50(D1):D622-d631.","journal-title":"Nucleic Acids Res"},{"key":"4288_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/nar\/gkn810","volume":"37","author":"DS Wishart","year":"2009","unstructured":"Wishart DS, et al. HMDB: a knowledgebase for the human metabolome. Nucl Acids Res. 2009;37:603\u201310.","journal-title":"Nucl Acids Res"},{"issue":"D1","key":"4288_CR33","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucl Acids Res. 2023;51(D1):D587-d592.","journal-title":"Nucl Acids Res"},{"issue":"D1","key":"4288_CR34","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucl Acids Res. 2017;45(D1):D353-d361.","journal-title":"Nucl Acids Res"},{"key":"4288_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-024-00934-3","author":"M Yuan","year":"2024","unstructured":"Yuan M, et al. Convenient synthesis and delivery of a megabase-scale designer accessory chromosome empower biosynthetic capacity. Cell Res. 2024. https:\/\/doi.org\/10.1038\/s41422-024-00934-3.","journal-title":"Cell Res"},{"key":"4288_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15020134","author":"M Yunchen","year":"2025","unstructured":"Yunchen M, et al. Metabolomic profiling of the striatum in Shank3 knockout ASD rats: effects of early swimming regulation. Metabolites. 2025. https:\/\/doi.org\/10.3390\/metabo15020134.","journal-title":"Metabolites"},{"key":"4288_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2164-6-60","volume":"6","author":"E Altermann","year":"2005","unstructured":"Altermann E, Klaenhammer TR. PathwayVoyager: pathway mapping using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. BMC Genomics. 2005;6:60.","journal-title":"BMC Genomics"},{"key":"4288_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1646905","author":"Z Zhuchen","year":"2020","unstructured":"Zhuchen Z, et al. Applications of network pharmacology in Traditional Chinese Medicine research. Evid Based Complement Alternat Med. 2020. https:\/\/doi.org\/10.1155\/2020\/1646905.","journal-title":"Evid Based Complement Alternat Med"},{"key":"4288_CR39","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.49126","author":"Z Xi","year":"2021","unstructured":"Xi Z, et al. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma. Int J Med Sci. 2021. https:\/\/doi.org\/10.7150\/ijms.49126.","journal-title":"Int J Med Sci"},{"key":"4288_CR40","doi-asserted-by":"publisher","first-page":"D400","DOI":"10.1093\/nar\/gkr1132","volume":"40","author":"Y Wang","year":"2012","unstructured":"Wang Y, et al. PubChem\u2019s bioassay database. Nucl Acids Res. 2012;40:D400-12.","journal-title":"Nucl Acids Res"},{"issue":"D1","key":"4288_CR41","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim S, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019;47(D1):D1102-d1109.","journal-title":"Nucleic Acids Res"},{"key":"4288_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-021-00446-x","author":"C Jiye","year":"2021","unstructured":"Jiye C, et al. Potential mechanisms of Guizhi decoction against hypertension based on network pharmacology and Dahl salt-sensitive rat model. Chin Med. 2021. https:\/\/doi.org\/10.1186\/s13020-021-00446-x.","journal-title":"Chin Med"},{"issue":"W1","key":"4288_CR43","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, et al. CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucl Acids Res. 2022;50(W1):W159-w164.","journal-title":"Nucl Acids Res"},{"issue":"7","key":"4288_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"4288_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18(3):151\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4288_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2024.07.003","author":"Y Liang","year":"2024","unstructured":"Liang Y, et al. Metabolomics reveals dysregulated all-trans retinoic acid and polyunsaturated fatty acid metabolism contribute to PXR-induced hepatic steatosis in mice. Toxicol Lett. 2024. https:\/\/doi.org\/10.1016\/j.toxlet.2024.07.003.","journal-title":"Toxicol Lett"},{"key":"4288_CR47","doi-asserted-by":"publisher","DOI":"10.21037\/tgh-24-35","author":"W Xin","year":"2025","unstructured":"Xin W, et al. Comprehensive gut microbiota and metabolomics combined with network pharmacology reveal the effects of acupuncture treatment for chemotherapy-induced nausea and vomiting. Transl Gastroenterol Hepatol. 2025. https:\/\/doi.org\/10.21037\/tgh-24-35.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"4288_CR48","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S500719","author":"H Liyuan","year":"2025","unstructured":"Liyuan H, et al. A review of the therapeutic potential of Ginseng and its bioactive components in nonalcoholic fatty liver disease. Drug Des Devel Ther. 2025. https:\/\/doi.org\/10.2147\/DDDT.S500719.","journal-title":"Drug Des Devel Ther"},{"issue":"10","key":"4288_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107754","volume":"26","author":"P Liu","year":"2023","unstructured":"Liu P, et al. Aggravated hepatic fibrosis induced by phenylalanine and tyrosine was ameliorated by chitooligosaccharides supplementation. iScience. 2023;26(10):107754.","journal-title":"iScience"},{"key":"4288_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13380","author":"L Youngmin A","year":"2021","unstructured":"Youngmin A L, Scott L F. Inflammatory and fibrotic mechanisms in NAFLD-implications for new treatment strategies. J Intern Med. 2021. https:\/\/doi.org\/10.1111\/joim.13380.","journal-title":"J Intern Med"},{"issue":"1","key":"4288_CR51","first-page":"81","volume":"13","author":"P Tessari","year":"2010","unstructured":"Tessari P, et al. Effect of liver cirrhosis on phenylalanine and tyrosine metabolism. Curr Opin Clin Nutr Metab Care. 2010;13(1):81\u20136.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"4288_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112747","volume":"139","author":"XM Xie","year":"2024","unstructured":"Xie XM, et al. Role of gut\/liver metabolites and gut microbiota in liver fibrosis caused by cholestasis. Int Immunopharmacol. 2024;139:112747.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"4288_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00148-25","volume":"13","author":"S Feng","year":"2025","unstructured":"Feng S, et al. Role of NLRP3 in the metabolism of bile acids and gut microbiota in CCl4-induced liver fibrosis. Microbiol Spectr. 2025;13(9):e0014825.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"4288_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1911534","volume":"13","author":"O Juanola","year":"2021","unstructured":"Juanola O, et al. Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns. Gut Microbes. 2021;13(1):1\u201320.","journal-title":"Gut Microbes"},{"key":"4288_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156501","volume":"139","author":"C Shao","year":"2025","unstructured":"Shao C, et al. JTCD attenuates HF by inhibiting activation of HSCs through PPAR\u03b1-TFEB axis-mediated lipophagy. Phytomedicine. 2025;139:156501.","journal-title":"Phytomedicine"},{"key":"4288_CR56","doi-asserted-by":"publisher","first-page":"9975","DOI":"10.2147\/JIR.S480574","volume":"17","author":"X Xu","year":"2024","unstructured":"Xu X, et al. Regulation of inflammation, lipid metabolism, and liver fibrosis by core genes of M1 macrophages in NASH. J Inflamm Res. 2024;17:9975\u201386.","journal-title":"J Inflamm Res"},{"key":"4288_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14047","author":"K Ibeas","year":"2023","unstructured":"Kevin I, et al. Cpt1a silencing in AgRP neurons improves cognitive and physical capacity and promotes healthy aging in male mice. Aging Cell. 2023. https:\/\/doi.org\/10.1111\/acel.14047.","journal-title":"Aging Cell"},{"key":"4288_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091894","author":"M Jingyi","year":"2022","unstructured":"Jingyi M, Virender K, Ram I M. Nanoparticle delivery of novel PDE4B inhibitor for the treatment of alcoholic liver disease. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14091894.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4288_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05451-5","volume":"82","author":"H Lin","year":"2024","unstructured":"Lin H, et al. Gram-negative bacteria-driven increase of cytosolic phospholipase A2 leads to activation of Kupffer cells. Cell Mol Life Sci. 2024;82(1):22.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"4288_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2020.104034","volume":"64","author":"P Boonsimma","year":"2021","unstructured":"Boonsimma P, et al. A patient with atypical presentation of chronic hepatosteatosis harboring a novel variant in the CPT1A gene. Eur J Med Genet. 2021;64(1):104034.","journal-title":"Eur J Med Genet"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04288-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:04:46Z","timestamp":1787396686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04288-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["4288"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04288-7","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We all declare that we have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Laboratory Animals, Guangdong Provincial Medical Laboratory Animal Center. (D202409-2).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}